Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07092540 · ClinicalTrials.gov registry record
The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy
A clinical trial, sponsored by University of Rochester.
- Recruiting
- Registry status
- 105
- Enrollment target
NCT07092540 is a clinical trial that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 105 participants.
The verdict
NCT07092540 is actively recruiting participants, sponsored by University of Rochester.
- RECRUITING
- Registry status
- 105 participants
- Enrollment target
Study Summary
The aim of the BABY DUCHENNE study is to evaluate the natural history and characterize the early clinical outcomes in very young children (0-3 years) with Duchenne muscular dystrophy (DMD) identified by newborn screening programs.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2026-05-30 |
| Est. Completion | 2029-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07092540
The ClinicalTrials.gov registry entry for NCT07092540 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07092540 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07092540 about?
NCT07092540 is a clinical study titled "The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy". The aim of the BABY DUCHENNE study is to evaluate the natural history and characterize the early clinical outcomes in very young children (0-3 years) with Duchenne muscular dystrophy (DMD) identified by newborn screening programs.
What is the current status of trial NCT07092540?
This trial is currently recruiting. The enrollment target is 105 participants. The study started on 2026-05-30. Estimated completion is 2029-08-31.
Who is sponsoring clinical trial NCT07092540?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.